Patient Expectations After Distal Radius ORIF: A Guide for Surgeons.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 42750604.
- Also identified by DOI 10.1177/15589447261483202.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Volar plate fixation is commonly used by orthopedic surgeons to treat distal radius fractures. This study aims to describe timelines and provide a practical guide for patient counseling following distal radius open reduction internal fixation. A retrospective observational study of patients undergoing fixation of distal radius fractures (Current Procedural Terminology [CPT] codes 25607-25609) by a single surgeon at a private orthopedic practice between December 2023 and June 2025. The study analyzed deidentified postoperative survey data, including pain, subjective function, return to work, driving, and hand therapy utilization. Thirty-four patients (mean age = 51.3 ± 17.1 years; 85.3% female) were included. Mean pain decreased from 4.34 ± 2.84 at 2 weeks to 1.08 ± 1.39 at 3 months, whereas subjective function improved from 18.4% ± 20.5% to 84.0% ± 14.2% of normal over the same period; the mean times to return to driving and work were 12.0 ± 11.4 days and 23.0 ± 25.3 days, respectively. Higher pain was consistently associated with lower functional recovery at all time points (<i>r</i> = -0.41 to -0.56, all <i>P</i> ≤ .016), and the CPT code 25608 was associated with lower odds of achieving this threshold (odds ratio, 0.06; <i>P</i> = .023). Patients undergoing volar plate fixation of distal radius fractures demonstrated pain reduction and improvement in function by 3 months, with variable return-to-work and driving timelines. These findings provide preliminary patient-centered recovery benchmarks that may help improve counseling and patient satisfaction but require validation in larger studies.<b>Level of Evidence:</b> Therapeutic III.